AI PROTEINS

Welcome to the Brand page for “AI PROTEINS”, which is offered here for Custom design, engineering, research, development and testing services in the field of peptide materials, polypeptide and miniprotein synthesis, protein and miniprotein uses for medical, scientific, agricultural, industrial and technological applications; pharmaceutical research and development; application service provider (asp) featuring software using artificial intelligence for designing protein and miniprotein pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; consulting services in the field of pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases, autoimmune diseases, infectious diseases, metabolic disorders, cognitive disorders, heart diseases, kidney diseases, neurological diseases, pain, inflammation and cancer; software as a service (saas) services featuring software using artificial intelligence for designing protein and miniprotein pharmaceuticals; and research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines;.

Its status is currently believed to be active. Its class is unavailable. “AI PROTEINS” is believed to be currently owned by “AI Proteins, Inc.”

Owner:
AI PROTEINS, INC.
Owner Details
Description:
Custom design, engineering, research, development and testing services in the field of peptide materials, polypeptide and miniprotein synthesis, protein and miniprotein uses for medical, scientific, agricultural, industrial and technological applications; Pharmaceutical research and development; Application service provider (ASP) featuring software using artificial intelligence for designing protein and miniprotein pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases, autoimmune diseases, infectious diseases, metabolic disorders, cognitive disorders, heart diseases, kidney diseases, neurological diseases, pain, inflammation and cancer; Software as a service (SAAS) services featuring software using artificial intelligence for designing protein and miniprotein pharmaceuticals; and Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines;
Categories: CUSTOM DESIGN